Inpatient Initiation of Buprenorphine Maintenance vs. Detoxification: Can Retention of Opioid-Dependent Patients in Outpatient Counseling Be Improved?

REFERENCES

• Jaffe JH, O'Keefe C. From morphine clinics to buprenorphine: regulating opioid agonist treatment in the United States. Drug Alcohol Depend. 2003;70:S3–S11. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bouchez J, Vignau J. The French experience—the pharmacist, general practitioner and patient perspective. Eur Addiction Res. 1998;4(Suppl 1):19–23. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Thirion X, Micallef J, Barrau K, , et al. Recent evolution in opiate dependence in France during the generalisation of maintenance treatments. Drug Alcohol Depend. 2001;61:281–285. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine for opioid dependence. JAMA. 1992;267:2750–2755. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993;181:358–364. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psych. 1994;151:1025–1030. [CSA]
   PubMed Web of Science ®Google Scholar
• Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend. 1995;40:17–25. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ling W, Wesson DR, Charuvastra C, Klett J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996;53:401–407. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ling W, Charuvastra C, Collins JF, , et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction. 1998;93:475–486. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Krook AL, Brors O, Dahlberg J, , et al. A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway. Addiction. 2002;97:533–542. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buprenorphine approval expands options for addiction treatment. NIDA Notes. 2002;17(4). Available at: http://www.drugabuse.gov/ NIDA_notes/NNVol17N4/ Buprenorphine.html, [CSA]
   Google Scholar
• Will buprenorphine usher in new era for opiate treatment? Alcohol & Drug Abuse Weekly. 2002;14(48): 1, 6–7. [INFOTRIEVE], [CSA]
   Google Scholar
• Elliot VS. New anti-addiction drug slow to catch on in primary care. American Medical News. Available at: http://www.ama-assn.org/amednews/2003/11/03/hlsb1103.htm. Accessed November 3, 2003. [CSA]
   Google Scholar
• Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend. 2003;70:S59–S77. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70:S13–S27. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tamaskar R, Parran Jr. TV, Heggi A, Brateanu A, Rabb M, Yu J. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study. J Addict Dis. 2003;22:5–12. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sobey PW, Parran Jr. TV, Grey SF, Adelman CL, Yu J. The use of tramadol for acute heroin withdrawal: a comparison to clonidine. J Addict Dis. 2003;22:13–25. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Threlkeld M, Parran T, Adelman C, Grey S, Yu J. Tramadol v. buprenorphine in the management of acute heroin withdrawal. Am J Addict. Accepted September 2004. [CSA]
   Web of Science ®Google Scholar
• Armenian SH, Chutuape MA, Stitzer SL. Predictors of discharge against medical advice from a short-term hospital detoxification unit. Drug Alcohol Depend. 1999;56:1–8. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mattick RP, Robert A, White JM, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction. 2003;98:441–452. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• National Poll of Physicians on Barriers to Widespread Buprenorphine Use. Available at: http://www.jointogether.org/sa/files/pdf/ bupereport.pdf.
   Google Scholar
• Barnett PG, Zaric GS, Brandeau ML. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction. 2001;96:1267–1278. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rosenheck R, Kosten T. Buprenorphine for opiate addiction: potential economic impact. Drug Alcohol Depend. 2001;63:253–262. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar